Anshuman Swain, MD
Pain Medicine · Logan, OHNPI 1669698544
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Nalu Medical, Inc. at 43.1% of the total. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $91.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$13K
- Stratus Medical, LLC$8K
- Abbott$2K
- Vertos Medical, Inc.$2K
- Boston Scientific$2K
- Vertiflex, Inc.$2K
- plus $2K from 15 others
What the payments were for
- Consulting fees$4,50015%
- Travel & lodging$7,46125%
- Food & beverage$17,86160%
- Education$700%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 94 | $12,880 |
| Stratus Medical, LLC | 90 | $7,925 |
| Abbott | 23 | $1,862 |
| Vertos Medical, Inc. | 21 | $1,733 |
| Boston Scientific | 57 | $1,601 |
| Vertiflex, Inc. | 8 | $1,570 |
| Stryker | 6 | $744 |
| ZOLL Respicardia, Inc. | 2 | $516 |
| Biotronik NRO, Inc. | 9 | $386 |
| Veryan Medical Incorporated | 1 | $248 |
| Spinefrontier, Inc. | 1 | $132 |
| Medicomp Inc | 2 | $73 |
| SPR Therapeutics, Inc | 2 | $66 |
| Saluda Medical Americas, Inc. | 2 | $29 |
| Avanos Medical | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$10,598
- Nimbus$6,757
- mild Device Kit$1,826
- Superion ISS$1,315
- PROCLAIM$1,206
- Superion Indirect Decompression System$749
- remede System$516
- Prospera$269
- BioMimics$248
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$189
- ETERNA$140
- OPTABLATE$132
- InSpan$132
- NanoFuse$132
- Proclaim Family of SCS IPGs$126
- GENERAL - THERAPIES$104
How this compares
$29,891 in reported general payments places this provider in the 90th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 110 | $87,160 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,874 | $60,581 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,190 | $29,795 |
| Oxycodone Hcl | 934 | $22,816 |
| Nucynta ErTapentadol Hcl | 12 | $14,496 |
| Pregabalin | 265 | $11,522 |
| Gabapentin | 680 | $10,472 |
| Naloxone Hcl | 189 | $10,055 |
| Buprenorphine | 30 | $7,684 |
| Fentanyl | 29 | $3,705 |
| Morphine Sulfate ErMorphine Sulfate | 129 | $2,747 |
| Lidocaine | 31 | $2,084 |
| Tizanidine Hcl | 290 | $1,802 |
| Metaxalone | 19 | $1,685 |
| Methadone Hcl | 105 | $1,567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er | $14 | $14,49612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 245 pain medicine providers in Ohio.
Other pain medicine in Logan
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.